A series of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives was optimized as Polo-like kinase 1 inhibitors. Extensive SAR afforded a highly potent and selective PLK1 compound. The compound showed good antiproliferative activity when tested in a panel of tumor cell lines with PLK1 related mechanism of action and with good in vivo antitumor efficacy in two xenograft models after i.v. administration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2010.09.060 | DOI Listing |
Publication Analysis
Top Keywords
potent selective
8
polo-like kinase
8
45-dihydro-1h-pyrazolo[43-h]quinazolines potent
4
selective polo-like
4
kinase plk1
4
plk1 inhibitors
4
inhibitors series
4
series 45-dihydro-1h-pyrazolo[43-h]quinazoline
4
45-dihydro-1h-pyrazolo[43-h]quinazoline derivatives
4
derivatives optimized
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!